MedPath
HSA Approval

MOXIFLOXACIN-AFT SOLUTION FOR INFUSION 400MG/250ML

SIN17231P

MOXIFLOXACIN-AFT SOLUTION FOR INFUSION 400MG/250ML

MOXIFLOXACIN-AFT SOLUTION FOR INFUSION 400MG/250ML

May 7, 2025

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INFUSION, SOLUTION

INTRAVENOUS

Medical Information

J01MA14

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Joint Stock Company "Halychpharm"

Active Ingredients

Moxifloxacin HCl eqv Moxifloxacin

400mg/250ml

Moxifloxacin

Documents

Package Inserts

MOXIFLOXACIN-AFT SOLUTION FOR INFUSION Package Insert.pdf

Approved: May 7, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.